Table 2. Rare Gastrointestinal Manifestations of CMV Infection.

Age, y	Sex	Recipient	Donor	Time b	Type of transplantation	Induction or antirejection medication	Signs	Diagnosis	Treatment
37	F a	+	+	30 d	kidney	Anti-CD52	Abdominal pain, bloody peritoneal fluid, leukopenia	Peritoneal fluid RT-PCR c, CMV-pp65 d	Peritoneal-catheter removal, medical therapy (34)
41	F	-	-	6 mo	-	ATG a	Abdominal pain, Pancreatitis	RT-PCR	Medical therapy (36)
46	F	+	+	2 mo	kidney	Basiliximab	Fever, abdominal pain, duodenal vasculitis	RT-PCR	Histology e, medical therapy (33)
50	M a	+	+	8 wk	Kidney, Liver	ATG	Abdominal pain, duodenal vasculitis, obstruction	RT-PCR	Histology, surgical resection (35)
58	F	+	+	6 mo	kidney	-	Fever, leukopenia, thrombocytopenia, painful hemorrhoid	CMV-PP65 Ag	Histology (32)
44	M	?	-	2 mo	Kidney	OKT3 F	Abdominal pain, diarrhea, leukopenia, large colonic veins thrombosis	Histology	Total colectomy (30)
62	M	+	+	4 y	heart	-	Abdominal pain, hematochezia, colonic stenosis	Histology	Surgical resection (31)

^aAbbreviation: ATG, antithymocyte globuline; F, female; M,male

^bTime at which the complication presents after transplantation.

^cRT-PCR, detection of CMV-DNA in plasma or other bodily fluid by real-time polymerase chain reaction.

^dCMV-pp65, detection of CMV-PP65 antigen.

^eHistology, that pathologic changes including CMV inclusion bodies have been found in involved tissues.

^FOKT3 is an anti Tcell murine monoclonal anibody.